Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
934.14
-5.64 (-0.60%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,858,283
Open
934.09
Bid (Size)
932.00 (1)
Ask (Size)
935.00 (2)
Prev. Close
939.78
Today's Range
918.62 - 942.88
52wk Range
434.34 - 945.69
Shares Outstanding
N/A
Dividend Yield
0.48%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
First Choice Neurology Pioneering Neurologists Administer the New FDA-Approved Drug Kisunla
Today 19:05 EDT
JUPITER, Fla. - July 11, 2024 - PRLog -- First Choice Neurology, the largest neurology group in the United States, is set to make medical history next week as Dr. Jennifer Buczyner and Dr. Jeff Gelblum...
Via
PRLog
Exposures
Product Safety
Eli Lilly, Novo Nordisk Shares Dip As Pfizer Ramps Up Diabetes Drug Competition
Today 16:10 EDT
Shares of Eli Lilly and Co (NYSE: LLY) and Novo Nordisk A/S (NYSE: NVO) are facing declines Thursday, maybe influenced by competitive developments and regulatory updates in the pharmaceutical sector.
Via
Benzinga
Performance
YTD
+57.74%
+57.74%
1 Month
+7.89%
+7.89%
3 Month
+22.98%
+22.98%
6 Month
+46.94%
+46.94%
1 Year
+112.02%
+112.02%
More News
Read More
Bernie Sanders Targets High Prices of Ozempic and Wegovy In US
Today 13:47 EDT
Via
Benzinga
3 Future Blue-Chip Stocks That Could Make You Rich
Today 10:10 EDT
Via
InvestorPlace
Better Growth Play: Eli Lilly vs. Vanguard Growth Index Fund ETF Shares
Today 5:30 EDT
Via
The Motley Fool
Topics
ETFs
Warren Buffett Recommends This Magnificent Index Fund. It Could Turn $500 Per Month Into $986,900
Today 5:12 EDT
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Eli Lilly Announces CFO Change
July 10, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
July 09, 2024
Via
Benzinga
Jim Cramer Identifies Eight Companies Eyeing Trillion-Dollar Club — Elon Musk's Tesla, Eli Lilly Top Contenders
Today 3:00 EDT
Via
Benzinga
3 Pharma Stocks That Could Make Your Grandchildren Rich
July 10, 2024
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
July 10, 2024
Via
Benzinga
Only 25% Patients Stick With Novo Nordisk's Wegovy Or Ozempic After 2 Years, A Study Shows; Company Calls Data Insufficient
July 10, 2024
Via
Benzinga
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
July 09, 2024
Via
Benzinga
Eli Lilly Finalizes Acquisition Agreement to Acquire Morphic for $3.2 Billion – InsideArbitrage
July 09, 2024
Via
AB Newswire
Hot Stocks: 3 Sleeping Giants About to Dominate Their Sectors
July 09, 2024
Via
InvestorPlace
3 Moonshot Stocks With the Potential to Turn $10K Into $1 Million
July 09, 2024
Via
InvestorPlace
Summer 2024 Snapshot Of The S&P 500's Market Cap
July 09, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug
July 09, 2024
Via
MarketBeat
7 Bullish Stock Picks With the Potential to Turn $5K Into $50K
July 09, 2024
Via
InvestorPlace
Is Eli Lilly Stock a No-Brainer Buy After Its FDA Alzheimer's Disease Drug Win?
July 09, 2024
Via
The Motley Fool
Exposures
Product Safety
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
July 09, 2024
Via
The Motley Fool
S&P 500 Closes At Record High Ahead Of Inflation Data: Fear & Greed Index Remains In 'Neutral' Zone
July 09, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
July 09, 2024
Via
Benzinga
Patients Lost More Weight On Eli Lilly's Mounjaro Than Novo Nordisk's Ozempic
July 08, 2024
Via
Investor's Business Daily
A $2.5 Trillion Opportunity In The Biotech Industry
July 08, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.